Damloran Pharmaceutical (XTEH:DAML1) Research & Development: IRR Mil (TTM As of . 20)


XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Research & Development?

Damloran Pharmaceutical XTEH:DAML1 27 Research & Development is IRR Mil as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

Research & Development is the aggregate amount of research and development expenses during the year. Damloran Pharmaceutical's Research & Development for the six months ended in . 20 was IRR0.00 Mil. Damloran Pharmaceutical does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Damloran Pharmaceutical  (XTEH:DAML1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Damloran Pharmaceutical Research & Development Related Terms

Damloran Pharmaceutical Research & Development Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Research & Development Chart

Damloran Pharmaceutical Annual Data
Trend
Research & Development

Damloran Pharmaceutical Semi-Annual Data
Research & Development
XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of IRR Mil mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Research & Development of IRR Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's Research & Development too high?
Damloran Pharmaceutical's current Research & Development is IRR Mil. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Research & Development compare to IMNPQ?
Damloran Pharmaceutical's Research & Development of IRR Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Damloran Pharmaceutical and its competitors. Damloran Pharmaceutical's current Research & Development is IRR Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Research & Development of IRR Mil. The current Research & Development is IRR Mil. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Research & Development is IRR Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price